Increased Risk of Type 2 Diabetes
A study conducted by researchers from the University of Oklahoma Health Sciences Center reveals that estrogen supplementation after menopause may increase the risk of Type 2 diabetes. Based on 850 American Indian women; who are at high risk for the disease, the study examined the relationship between estrogen use and glucose and insulin levels, along with the risk of type 2 diabetes. The results show a link between estrogen use and lower fasting blood sugar levels, but higher levels of the 2-h glucose level. Although there is no direct correlation between estrogen use and an increased risk of diabetes in general, an increased risk became apparent when the therapy time lengthens. This area of concern however, has not been sufficiently explored. Previous studies have been limited to white women who are already at lower risk of the disease as compared to other ethnicities. SOURCE: Diabetes Care, 2002;25:500-504
Human Growth Hormone - Go Back Click here to Buy HGH Human Growth Hormone
|
Terms of Use - Privacy
Policy
Disclaimer: Content on this site is
for reference purposes and is not intended to substitute for
advice given by a physician, pharmacist, or other licensed
health-care professional. You should not use this information as
self-diagnosis or for treating a health problem or disease.
Links and content located on other sites is not our
responsibility. Do your own due diligence before purchasing any
product. Contact your health-care provider immediately if you
suspect that you have a medical problem. Information and
statements regarding dietary supplements have not been evaluated
by the Food and Drug Administration and are not intended to
diagnose, treat, cure, or prevent any disease or health
condition.